HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rodger Allen Selected Research

4- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrile

9/2004A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rodger Allen Research Topics

Disease

2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 05/2017
1Exanthema (Rash)
05/2017
1Neoplasm Metastasis (Metastasis)
09/2004
1Neoplasms (Cancer)
09/2004

Drug/Important Bio-Agent (IBA)

2seletalisibIBA
01/2018 - 05/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2004
1Phosphotransferases (Kinase)IBA
09/2004
1Paclitaxel (Taxol)FDA LinkGeneric
09/2004
1Angiogenesis InhibitorsIBA
09/2004
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2004
14- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrileIBA
09/2004

Therapy/Procedure

1Therapeutics
09/2004
1Aftercare (After-Treatment)
09/2004